PT - JOURNAL ARTICLE AU - Soliman, Nada AU - Almishal, Ruba AU - Elsayed, Basant AU - Ahmed, Ayaaz AU - Al-Amri, Sara AU - Al-Kuwari, Aisha AU - Al-Muhannadi, Shaikha AU - Nadeer, Muhammed AU - Chivese, Tawanda TI - Association between diabetes and levels of micro-nutrients in a Middle Eastern population - A case-control study AID - 10.1101/2023.07.11.23292494 DP - 2023 Jan 01 TA - medRxiv PG - 2023.07.11.23292494 4099 - http://medrxiv.org/content/early/2023/07/12/2023.07.11.23292494.short 4100 - http://medrxiv.org/content/early/2023/07/12/2023.07.11.23292494.full AB - Objective To investigate associations between levels of micronutrients and diabetes, controlled and uncontrolled diabetes.Methods A case-control study, matched on age and gender, was performed on participants with (cases) and without diabetes (controls), who were Qatari or long-term residents. Participants with diabetes were divided into those with controlled and uncontrolled diabetes using an HbA1c cutoff of 7%. Levels of micronutrients were measured from serum and categorized into normal and abnormal levels.Results A total of 1118 participants (374 cases and 744 controls) were included with a mean age of 41.7 years (SD 9.9), of whom 53.9% were female. Of those with diabetes, 229 had controlled diabetes and 145 had uncontrolled diabetes. Compared to those without diabetes, participants with diabetes had significantly lower mean magnesium (0.80 mmol/L (SD 0.07) vs 0.84 mmol/L (SD 0.06), respectively, p<0.001). Lower magnesium and iron were observed in participants with uncontrolled compared to participants with controlled diabetes. After multivariable logistic regression, diabetes was associated with hypomagnesemia (OR 3.2, 95% CI 3.4-213.9), and low iron (OR 1.49, 95% CI 1.03-2.15). Uncontrolled diabetes showed stronger odds of association with hypomagnesemia (OR 5.57, 95% CI 3.65-8.52).Conclusion In an affluent setting in the Middle East and North Africa (MENA) region, diabetes was associated with low magnesium and low iron, and this association was worse in individuals with uncontrolled diabetes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study received ethical approval from the Qatar University Institutional Review Board (QU-IRB) (reference number QU IRB1228 E20) and the Qatar Biobank IRB (reference number QF QBB RES ACC 0186).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsFe(Iron)Mg(Magnesium)Zn(Zinc)Cu(Copper)MENA(Middle East and North Africa)HbA1c(glycated hemoglobin)BMI(Body Mass Index)HDL(High Density Lipoprotein)LDL(Low Density Lipoprotein)BP(Blood Pressure)OR(Odds Ratio)CI(Confidence Interval)β(beta coefficient)RCT(Randomized Control Trial)